ToolGen, 10 Billion Won Osong R&D Center New Construction Project
[Asia Economy Reporter Minji Lee] ToolGen announced on the 16th that it has decided to construct the Osong R&D Center with a budget of 10 billion KRW. This corresponds to 10.12% of its equity capital.
Hot Picks Today
"It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company stated, "This is to carry out the CRISPR gene-editing R&D project and to create network synergy among clusters within the Osong Advanced Medical Complex." The investment period is until December 16, 2023.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.